169 related articles for article (PubMed ID: 10507269)
21. Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience.
Szefler SJ; Lyzell E; Fitzpatrick S; Cruz-Rivera M
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):83-90. PubMed ID: 15281476
[TBL] [Abstract][Full Text] [Related]
22. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
Scott MB; Skoner DP
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
[TBL] [Abstract][Full Text] [Related]
23. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes.
Volovitz B; Soferman R; Blau H; Nussinovitch M; Varsano I
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):464-9. PubMed ID: 9564798
[TBL] [Abstract][Full Text] [Related]
24. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
Weng JL; Zheng YS; Ma QF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
[TBL] [Abstract][Full Text] [Related]
25. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.
Busse WW; Pedersen S; Pauwels RA; Tan WC; Chen YZ; Lamm CJ; O'Byrne PM;
J Allergy Clin Immunol; 2008 May; 121(5):1167-74. PubMed ID: 18405951
[TBL] [Abstract][Full Text] [Related]
26. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
[TBL] [Abstract][Full Text] [Related]
27. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma.
Kemp J; Wanderer AA; Ramsdell J; Southern DL; Weiss S; Aaronson D; Grossman J
Ann Allergy Asthma Immunol; 1999 May; 82(5):463-71. PubMed ID: 10353578
[TBL] [Abstract][Full Text] [Related]
28. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
O'Connell EJ
Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
[TBL] [Abstract][Full Text] [Related]
29. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.
Szefler SJ; Eigen H
J Allergy Clin Immunol; 2002 Apr; 109(4):730-42. PubMed ID: 11941331
[TBL] [Abstract][Full Text] [Related]
30. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
[TBL] [Abstract][Full Text] [Related]
31. Clinical use of nebulized budesonide inhalation suspension in a child with asthma.
Skoner DP; Angelini BL; Friday G; Gentile D
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):210-4. PubMed ID: 10518848
[TBL] [Abstract][Full Text] [Related]
32. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.
Hvizdos KM; Jarvis B
Drugs; 2000 Nov; 60(5):1141-78. PubMed ID: 11129126
[TBL] [Abstract][Full Text] [Related]
33. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
McLaughlin T; Leibman C; Patel P; Camargo CA
Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
Gradman J; Wolthers OD
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
[TBL] [Abstract][Full Text] [Related]
36. A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma.
Williamson PA; Menzies D; Nair A; Tutuncu A; Lipworth BJ
Ann Allergy Asthma Immunol; 2009 Feb; 102(2):161-7. PubMed ID: 19230469
[TBL] [Abstract][Full Text] [Related]
37. Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children.
Basu K; Nair A; Williamson PA; Mukhopadhyay S; Lipworth BJ
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):436-41. PubMed ID: 19927544
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a nighttime sleep diary in asthmatic children.
Yoshihara S; Kanno N; Fukuda H; Yamada Y; Fukuda N; Tsuchiya T; Arisaka O
Pediatr Allergy Immunol; 2011 Nov; 22(7):667-70. PubMed ID: 21950678
[TBL] [Abstract][Full Text] [Related]
39. The use of inhaled corticosteroids for persistent asthma in infants and young children.
Berger WE; Shapiro GG
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):387-399; quiz 399-402, 463. PubMed ID: 15104189
[TBL] [Abstract][Full Text] [Related]
40. Twice-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Mendelson L; Cook D; Cruz-Rivera M; Fitzpatrick S; Smith JA
J Asthma; 2002 May; 39(3):227-37. PubMed ID: 12043854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
